Please join us on Wednesday, March 13th at 1:30pm EDT for a special, live webinar led by Dr. Anupam Jena, MD, PhD: What Do Value Assessments Miss: Rethinking Value Using New Health Economics Evidence
In this unique one-hour webinar, Dr. Jena will outline a broader framework for assessing value to improve identification of not only the highest-value treatments, but also low-value therapies on which spending can safely be reduced.
In a special feature focused on drug pricing solutions and value, PharmaLive’s Christiane Truelove talks with Precision subject matter experts Jeremy Schafer and Jason Shafrin, who offer their perspectives on the complex landscape.
As the spotlight on manufacturers’ raising the prices of therapies already on the market shows no sign of dimming, one industry group recently unveiled its intentions to dig a little deeper into the topic. The Institute for Clinical and Economic Review (ICER) says it will create a series of so-called Unsupported Price Increase (UPI) reports that will examine whether price increases are justified.
We are pleased to announce that Precision’s Chief Scientist Dr. Jeroen Jansen will be participating in a special workshop organized by ISPOR on the topic of value assessments. The workshop, part of ISPOR’s ongoing Summit Series, will take place on Thursday, February 28th, 2019 at 12:00pm EST. Entitled Novel Approaches to Value Assessment, WITHIN the Cost-Effectiveness Framework, this webinar will feature a video presentation from Dr. Jansen as well as a live Q&A session at the conclusion with moderator Lou Garrison, PhD.
In a special commentary appearing in STAT News, Jacki Chou, Senior Director, Policy & Economics, and her co-author discuss overcoming 5 critical challenges in the US biosimilars marketplace, offering some strategic policy recommendations for the consideration of key healthcare stakeholders. […]